Carl Atkinson to Mice, Transgenic
This is a "connection" page, showing publications Carl Atkinson has written about Mice, Transgenic.
Connection Strength
0.036
-
A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer. Blood. 2012 Jun 21; 119(25):6043-51.
Score: 0.020
-
Modulation of protective T cell immunity by complement inhibitor expression on tumor cells. Cancer Res. 2008 Aug 15; 68(16):6734-42.
Score: 0.016